Axovant axovant.com


Public lists: Pharma Startups (4732)

Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and impaired daily function. Axovant's goal is to be the leading global dementia solutions company, targeting this complex condition through multiple pharmacologic mechanisms of action.

Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and ...Show all

Company (IPO / Went public)

Phone: 441-532-8833

Fax:

Clarendon House

 Hamilton, HM 11
 Bermuda

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Axovant $315M Jun 11, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Axovant Jobs

jobs by Indeed job search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline Jul 17, 2015 Nov 07, 2017 Patent
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline Dec 10, 2008 Jul 21, 2015 Patent
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline Sep 28, 2017 Application
Compositions and methods of treating a neurodegenerative disease Aug 15, 2017 Application
Methods of improving balance, gait or both in patients with neurological disease Feb 27, 2017 Application
See all 10 patents